Statins research unfinished saga: desirability versus feasibility

por Fisman, Enrique Z, Adler, Yehuda, Tenenbaum, Alexander
Publicado 2005

Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins

por Tenenbaum, Alexander, Fisman, Enrique Z, Motro, Michael, Adler, Yehuda
Publicado 2006

Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus

por Tenenbaum, Alexander, Fisman, Enrique Z, Schwammenthal, Ehud, Adler, Yehuda, Benderly, Michal, Motro, Michael, Shemesh, Joseph
Publicado 2003

Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impair...

por Node, Koichi, Inoue, Teruo, Boyko, Valentin, Goldberg, Ilan, Fisman, Enrique Z, Adler, Yehuda, Schwammenthal, Ehud, Matas, Zipora, Behar, Solomon, Tenenbaum, Alexander
Publicado 2009

Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment

por Burazor, Ivana, Aviel-Ronen, Sarit, Imazio, Massimo, Goitein, Orly, Perelman, Marina, Shelestovich, Natalia, Radovanovic, Ninoslav, Kanjuh, Vladimir, Barshack, Iris, Adler, Yehuda
Publicado 2018

Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?

por Tenenbaum, Alexander, Boyko, Valentina, Fisman, Enrique Z, Goldenberg, Ilan, Adler, Yehuda, Feinberg, Micha S, Motro, Michael, Tanne, David, Shemesh, Joseph, Schwammenthal, Ehud, Behar, Solomon
Publicado 2008

CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis

por Markel, Gal, Imazio, Massimo, Koren-Morag, Nira, Galore-Haskel, Gilli, Schachter, Jacob, Besser, Michal, Cumetti, Davide, Maestroni, Silvia, Altman, Arie, Shoenfeld, Yehuda, Brucato, Antonio, Adler, Yehuda
Publicado 2016